{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:39:52Z","timestamp":1789767592429,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s40291-024-00736-8","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T18:01:51Z","timestamp":1723744911000},"page":"803-810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Profiling Cell-Free DNA from Malignant Pleural Effusion for Oncogenic Driver Mutations in Patients with Treatment-Naive Stage IV Adenocarcinoma: A Multicenter Prospective Study"],"prefix":"10.1007","volume":"28","author":[{"given":"Shih-Chieh","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Feng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Chi","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7196-3504","authenticated-orcid":false,"given":"Cheng-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"736_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17:362\u201387. https:\/\/doi.org\/10.1016\/j.jtho.2021.11.003.","journal-title":"J Thorac Oncol"},{"key":"736_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","volume":"20","author":"E Heitzer","year":"2019","unstructured":"Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20:71\u201388. https:\/\/doi.org\/10.1038\/s41576-018-0071-5.","journal-title":"Nat Rev Genet"},{"key":"736_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.gendis.2022.07.023","volume":"10","author":"H Padinharayil","year":"2023","unstructured":"Padinharayil H, Varghese J, John MC, Rajanikant GK, Wilson CM, Al-Yozbaki M, et al. Non-small cell lung carcinoma (NSCLC): implications on molecular pathology and advances in early diagnostics and therapeutics. Genes Dis. 2023;10:960\u201389. https:\/\/doi.org\/10.1016\/j.gendis.2022.07.023.","journal-title":"Genes Dis."},{"key":"736_CR4","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.7150\/thno.16558","volume":"7","author":"T Xu","year":"2017","unstructured":"Xu T, Kang X, You X, Dai L, Tian D, Yan W, et al. Cross-platform comparison of four leading technologies for detecting EGFR mutations in circulating tumor DNA from non-small cell lung carcinoma patient plasma. Theranostics. 2017;7:1437\u201346. https:\/\/doi.org\/10.7150\/thno.16558.","journal-title":"Theranostics."},{"key":"736_CR5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","volume":"14","author":"F Diehl","year":"2008","unstructured":"Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14:985\u201390. https:\/\/doi.org\/10.1038\/nm.1789.","journal-title":"Nat Med"},{"issue":"Suppl 7","key":"736_CR6","doi-asserted-by":"publisher","first-page":"S882","DOI":"10.21037\/jtd.2018.03.81","volume":"10","author":"M Santarpia","year":"2018","unstructured":"Santarpia M, Liguori A, Daveni A, Karachaliou N, Gonzalez-Cao M, Daffin\u00e0 MG, et al. Liquid biopsy for lung cancer early detection. J Thorac Dis. 2018;10(Suppl 7):S882\u201397. https:\/\/doi.org\/10.21037\/jtd.2018.03.81.","journal-title":"J Thorac Dis"},{"key":"736_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/2159-8290.CD-13-1014","volume":"4","author":"DA Haber","year":"2014","unstructured":"Haber DA, Velculescu VE. Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. Cancer Discov. 2014;4:650\u201361. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-1014.","journal-title":"Cancer Discov"},{"key":"736_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1164\/rccm.201203-0465PP","volume":"186","author":"GT Stathopoulos","year":"2012","unstructured":"Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med. 2012;186:487\u201392. https:\/\/doi.org\/10.1164\/rccm.201203-0465PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"736_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3816\/CLC.2006.n.043","volume":"8","author":"S Benlloch","year":"2006","unstructured":"Benlloch S, Mart\u00ed-Ciriqui\u00e1n JL, Galbis-Caravajal JM, Mart\u00edn C, S\u00e1nchez-Pay\u00e1 J, Rodr\u00edguez-Paniagua JM, et al. Cell-free DNA concentration in pleural fluid and serum: quantitative approach and potential prognostic factor in patients with cancer and pleural effusions. Clin Lung Cancer. 2006;8:140\u20135. https:\/\/doi.org\/10.3816\/CLC.2006.n.043.","journal-title":"Clin Lung Cancer"},{"issue":"19","key":"736_CR10","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.7150\/thno.34070","volume":"9","author":"L Tong","year":"2019","unstructured":"Tong L, Ding N, Wang X, Li J, Zhang Y, Xu X, et al. Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics. 2019;9(19):5532\u201341. https:\/\/doi.org\/10.7150\/thno.34070.","journal-title":"Theranostics"},{"key":"736_CR11","first-page":"19","volume":"41","author":"KC Ong","year":"2000","unstructured":"Ong KC, Indumathi V, Poh WT, Ong YY. The diagnostic yield of pleural fluid cytology in malignant pleural effusions. Singap Med J. 2000;41:19\u201323.","journal-title":"Singap Med J"},{"key":"736_CR12","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2023.1294","author":"H Yi","year":"2024","unstructured":"Yi H, Youk J, Lim Y, Roh H, Roh D, Kyung D, et al. Analytical and clinical validation of a highly sensitive NGS-based ctDNA assay with real-world concordance in NSCLC. Cancer Res Treat. 2024. https:\/\/doi.org\/10.4143\/crt.2023.1294.","journal-title":"Cancer Res Treat"},{"key":"736_CR13","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/cancers15102847","volume":"15","author":"SH Jeong","year":"2023","unstructured":"Jeong SH, Kyung D, Yuk HD, Jeong CW, Lee W, Yoon JK, et al. Practical utility of liquid biopsies for evaluating genomic alterations in castration-resistant prostate cancer. Cancers. 2023;15:2847. https:\/\/doi.org\/10.3390\/cancers15102847.","journal-title":"Cancers"},{"key":"736_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41416-022-01837-z","volume":"127","author":"S Kim","year":"2022","unstructured":"Kim S, Lim Y, Kang JK, Kim HP, Roh H, Kim SY, et al. Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment. Br J Cancer. 2022;127:898\u2013907. https:\/\/doi.org\/10.1038\/s41416-022-01837-z.","journal-title":"Br J Cancer"},{"key":"736_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.lungcan.2007.10.011","volume":"60","author":"X Zhang","year":"2008","unstructured":"Zhang X, Zhao Y, Wang M, Yap WS, Chang AY. Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer. Lung Cancer. 2008;60:175\u201382. https:\/\/doi.org\/10.1016\/j.lungcan.2007.10.011.","journal-title":"Lung Cancer"},{"key":"736_CR16","doi-asserted-by":"publisher","first-page":"67810","DOI":"10.18632\/oncotarget.18866","volume":"8","author":"J Gu","year":"2017","unstructured":"Gu J, Zang W, Liu B, Li L, Huang L, Li S, et al. Evaluation of digital PCR for detecting low-level EGFR mutations in advanced lung adenocarcinoma patients: a cross-platform comparison study. Oncotarget. 2017;8:67810\u201320. https:\/\/doi.org\/10.18632\/oncotarget.18866.","journal-title":"Oncotarget"},{"key":"736_CR17","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.7150\/thno.34070","volume":"9","author":"L Tong","year":"2019","unstructured":"Tong L, Ding N, Tong X, Li J, Zhang Y, Wang X, et al. Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics. 2019;9:5532\u201341. https:\/\/doi.org\/10.7150\/thno.34070.","journal-title":"Theranostics."},{"key":"736_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/LBR.0000000000000534","volume":"26","author":"A Demaio","year":"2019","unstructured":"Demaio A, Clarke JM, Dash R, Sebastian S, Wahidi MM, Shofer SL, et al. Yield of malignant pleural effusion for detection of oncogenic driver mutations in lung adenocarcinoma. J Bronchology Interv Pulmonol. 2019;26:96\u2013101. https:\/\/doi.org\/10.1097\/LBR.0000000000000534.","journal-title":"J Bronchology Interv Pulmonol."},{"key":"736_CR19","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.21037\/tlcr-21-123","volume":"10","author":"M Dorry","year":"2021","unstructured":"Dorry M, Davidson K, Dash R, Jug R, Clarke JM, Nixon AB, et al. Pleural effusions associated with squamous cell lung carcinoma have a low diagnostic yield and a poor prognosis. Transl Lung Cancer Res. 2021;10:2500\u20138. https:\/\/doi.org\/10.21037\/tlcr-21-123.","journal-title":"Transl Lung Cancer Res."},{"key":"736_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.chest.2023.01.019","volume":"164","author":"K Mahmood","year":"2023","unstructured":"Mahmood K, Jampani P, Clarke JM, Wolf S, Wang X, Wahidi MM, et al. High yield of pleural cell-free DNA for diagnosis of oncogenic mutations in lung adenocarcinoma. Chest. 2023;164:252\u201361. https:\/\/doi.org\/10.1016\/j.chest.2023.01.019. (Epub 2023 Jan 21).","journal-title":"Chest"},{"key":"736_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/1759-7714.12932","volume":"10","author":"Y Yao","year":"2019","unstructured":"Yao Y, Peng M, Shen Q, Hu Q, Gong H, Li Q, et al. Detecting EGFR mutations and ALK\/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples. Thorac Cancer. 2019;10:193\u2013202. https:\/\/doi.org\/10.1111\/1759-7714.12932.","journal-title":"Thorac Cancer."},{"key":"736_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-024-03391-x","volume":"2","author":"N Wang","year":"2024","unstructured":"Wang N, Zhang Y, Wu J, Zhu Y, Wu Y, Huang B, et al. MET overexpression correlated with prognosis of EGFR-mutant treatment-na\u00efve advanced lung adenocarcinoma: a real-world retrospective study. Clin Transl Oncol. 2024;2:1\u20132. https:\/\/doi.org\/10.1007\/s12094-024-03391-x. (Online ahead of print).","journal-title":"Clin Transl Oncol"},{"key":"736_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s10020-020-00193-z","volume":"26","author":"D Sun","year":"2020","unstructured":"Sun D, Zhu Y, Zhu J, Tao J, Wei X, Wo Y, et al. Primary resistance to first-generation EGFR-TKIs induced by MDM2 amplification in NSCLC. Mol Med. 2020;26:66. https:\/\/doi.org\/10.1186\/s10020-020-00193-z.","journal-title":"Mol Med"},{"key":"736_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/(sici)1097-0339(199808)19:2<131::aid-dc14>3.0.co;2-g","volume":"19","author":"CW Bedrossian","year":"1998","unstructured":"Bedrossian CW. Diagnostic problems in serous effusions. Diagn Cytopathol. 1998;19:131\u20137. https:\/\/doi.org\/10.1002\/(sici)1097-0339(199808)19:2%3c131::aid-dc14%3e3.0.co;2-g.","journal-title":"Diagn Cytopathol"},{"key":"736_CR25","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/sj.bjc.6603428","volume":"95","author":"H Kimura","year":"2006","unstructured":"Kimura H, Fujiwara Y, Sone T, Kunitoh H, Tamura T, Kasahara K, et al. EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib. Br J Cancer. 2006;95:1390\u20135. https:\/\/doi.org\/10.1038\/sj.bjc.6603428.","journal-title":"Br J Cancer"}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-024-00736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-024-00736-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-024-00736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T21:10:42Z","timestamp":1729977042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-024-00736-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1007\/s40291-024-00736-8","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"31 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was obtained for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors S.C. Chang, C.Y. Chen, Y.F. Wei, Y.C. Lai, P.W. Hu, J.C. Hung, and C.Y. Chang declare that they have no conflicts of interest that might be relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Institutional Review Boards of Far Eastern Memorial Hospital (IRB No.: 111267-F), National Yang Ming Chiao Tung University Hospital (IRB No.: 2022A011), National Taiwan University Hospital Yunlin Branch (IRB No.: 202205102RIFD), and E-Da Hospital (IRB No.: EMRB-111-140). The study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data that support the findings of this study are available on request from the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Yu-Feng Wei, Chung-Yu Chen, and Shih-Chieh Chang contributed to data collection and analysis. Cheng-Yu Chang and Yu-Feng Wei helped finalize study concept and study design. Yi-Chun Lai, Po-Wei Hu, and Jui-Chi Hung contributed to acquisition of data. Cheng-Yu Chang and Shih-Chieh Chang drafted the manuscript. All authors contributed to the article and approved the submitted version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}